Interleukin 17 is a chief orchestrator of immunity

M Veldhoen - Nature immunology, 2017 - nature.com
Increased understanding of the biology of interleukin 17 (IL-17) has revealed that this
cytokine is a central player in immunity at the sites most exposed to microorganisms …

Interleukin-22: immunobiology and pathology

JA Dudakov, AM Hanash… - Annual review of …, 2015 - annualreviews.org
Interleukin-22 (IL-22) is a recently described IL-10 family cytokine that is produced by T
helper (Th) 17 cells, γδ T cells, NKT cells, and newly described innate lymphoid cells (ILCs) …

[HTML][HTML] Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis

E Guttman-Yassky, R Bissonnette, B Ungar… - Journal of Allergy and …, 2019 - Elsevier
Background Dupilumab is an IL-4 receptor α mAb inhibiting signaling of IL-4 and IL-13, key
drivers of type 2–driven inflammation, as demonstrated by its efficacy in patients with …

Distinct expression of interleukin (IL)-36 α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease

MA Boutet, G Bart, M Penhoat, J Amiaud… - Clinical & …, 2016 - academic.oup.com
Summary Interleukin (IL)-36α, IL-36β and IL-36γ are expressed highly in skin and are
involved in the pathogenesis of psoriasis, while the antagonists IL-36Ra or IL-38, another …

[HTML][HTML] Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in …

J Gao, F Chen, H Fang, J Mi, Q Qi, M Yang - Biological Research, 2020 - SciELO Chile
GAO, Jintao et al. Daphnetin inhibits proliferation and inflammatory response in human
HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice …

[HTML][HTML] IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment

L Mercurio, M Morelli, C Scarponi… - Cell death & …, 2018 - nature.com
IL-36 cytokines, a subgroup of IL-1 family, comprise IL-36α, IL-36β, and IL-36γ agonists,
abundantly expressed in psoriatic skin, and IL-36RA and IL-38 antagonists. In psoriatic skin …

[HTML][HTML] IL-38 ameliorates skin inflammation and limits IL-17 production from γδ T cells

Y Han, J Mora, A Huard, P da Silva, S Wiechmann… - Cell reports, 2019 - cell.com
Summary Interleukin-38 (IL-38) is a cytokine of the IL-1 family with a role in chronic
inflammation. However, its main cellular targets and receptors remain obscure. IL-38 is …

[HTML][HTML] Human skin explant model for the investigation of topical therapeutics

JE Neil, MB Brown, AC Williams - Scientific Reports, 2020 - nature.com
The development of in vitro and ex vivo models to mimic human illness is important not only
for scientific understanding and investigating therapeutic approaches but also to mitigate …

[HTML][HTML] IL-38: a new player in inflammatory autoimmune disorders

L Xie, Z Huang, H Li, X Liu, SG Zheng, W Su - Biomolecules, 2019 - mdpi.com
Interleukin (IL)-38, a newly discovered IL-1 family cytokine, is expressed in several tissues
and secreted by various cells. IL-38 has recently been reported to exert an anti-inflammatory …

[HTML][HTML] The changing landscape of alopecia areata: the therapeutic paradigm

Y Renert-Yuval, E Guttman-Yassky - Advances in therapy, 2017 - Springer
Alopecia areata (AA), a prevalent inflammatory cause of hair loss, lacks FDA-approved
therapeutics for extensive cases, which are associated with very poor rates of spontaneous …